Table 1.
Conceptual framework: Indicators and conclusions for presence of confounding by indication and healthy vaccinee bias in influenza vaccine effectiveness studies
Indicator | Conclusion | References |
---|---|---|
Vaccinated study participants have a higher proportion of comorbidities than unvaccinated study participants, as indicated by baseline characteristics | High risk of confounding by indication in the unadjusted data set | [6, 38] |
Vaccinated study participants have a lower proportion of comorbidities than unvaccinated study participants, as indicated by baseline characteristics | High risk of healthy vaccinee bias in the unadjusted data set | [35, 36] |
Inclusion of comorbidities in the regression model increases vaccine effectiveness | Confounding by indication has led to underestimation of vaccine effectiveness in the unadjusted data set | [7] |
Inclusion of comorbidities in the regression model decreases vaccine effectiveness | Healthy vaccinee bias has led to overestimation of vaccine effectiveness in the unadjusted data set | [7] |
Significant effects of influenza vaccination appear outside the influenza season (“off-season estimates”), despite adjustment for comorbidities | Residual confounding by healthy vaccinee bias | [3, 11, 36] |